Brooklyn FI LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,752 shares of the healthcare conglomerate's stock, valued at approximately $1,392,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Geode Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the last quarter. Capital International Investors increased its stake in shares of UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $6,375,744,000. Northern Trust Corp grew its stake in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after buying an additional 861,854 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company's stock.
UnitedHealth Group Price Performance
UNH stock traded up $2.49 during trading on Wednesday, hitting $297.49. 15,953,133 shares of the stock traded hands, compared to its average volume of 6,692,836. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market cap of $269.87 billion, a price-to-earnings ratio of 19.19, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a 50 day simple moving average of $443.90 and a 200 day simple moving average of $500.04. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Robert W. Baird decreased their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.
Check Out Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report